IRCT20201110049329N1尚未招募3 期
The effect of Polypill V on cardiovascular events in patients with breast and colorectal cancer
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Study participants signed written informed consent, Cancer patients with no history of CVD, Having EF>50
排除标准
- •Having Contraindications to one of the components of the polypill V
研究者
相似试验
已完成
不适用
Improving Adherence using Combination TherapyHigh risk of cardiovascular diseaseCardiovascular - Normal development and function of the cardiovascular systemACTRN12606000067572Health Research Council of New Zealand600
已完成
不适用
The effect of different cardiovascular risk presentation formats on individuals? intentions, understanding and emotional affect.ISRCTN91319318Cardiff University (UK)800
进行中（未招募）
不适用
The short and long-term consequences of critical illness on the heart and blood vesselsMajor adverse cardiovasular events and arrhythmiaCirculatory SystemISRCTN15905609niversity of Oxford80,000
进行中（未招募）
1 期
This study is being carried out to evaluate the effect of a drug called dapagliflozin when added to current treatment for type 2 diabetes on cardiovascular events.Type 2 Diabetes mellitusMedDRA version: 20.0Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-000239-28-DEAstraZeneca AB17,160
招募中
不适用
Investigating cardiovascular adverse events related to cancer treatment: a study of extreme toxicity using induced pluripotent stem cellscardiovascular adverse events after cancer treatment1008220610027655NL-OMON44465niversitair Medisch Centrum Groningen48